{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:16:23Z","timestamp":1788336983279,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.neuropharm.2020.108289","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T07:27:37Z","timestamp":1599031657000},"page":"108289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats"],"prefix":"10.1016","volume":"180","author":[{"given":"Keila","family":"Navarro I Batista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Schraner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Riediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108289_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.neuropharm.2020.108289_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1152\/ajpcell.00142.2010","article-title":"Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle, American journal of physiology","volume":"300","author":"Allen","year":"2011","journal-title":"Cell physiology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib3","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1113\/jphysiol.2011.212845","article-title":"Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids","volume":"589","author":"Baehr","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib4","doi-asserted-by":"crossref","first-page":"R906","DOI":"10.1152\/ajpregu.1991.260.5.R906","article-title":"TNF-induced anorexia and learned food aversions are attenuated by area postrema lesions","volume":"260","author":"Bernstein","year":"1991","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib5","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2020.108289_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jcsm.12169","article-title":"Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1\/GDF15","volume":"8","author":"Borner","year":"2017","journal-title":"Journal of cachexia, sarcopenia and muscle"},{"key":"10.1016\/j.neuropharm.2020.108289_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","article-title":"Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat","volume":"131","author":"Borner","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2015.00012","article-title":"The regulation of muscle mass by endogenous glucocorticoids","volume":"6","author":"Braun","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib9","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1096\/fj.13-230375","article-title":"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle","volume":"27","author":"Braun","year":"2013","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/exnr.1993.1059","article-title":"Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system","volume":"120","author":"Broadwell","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia","volume":"54","author":"Burfeind","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jcsm.12054","article-title":"Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling","volume":"7","author":"Chen","year":"2016","journal-title":"Journal of cachexia, sarcopenia and muscle"},{"key":"10.1016\/j.neuropharm.2020.108289_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1523\/JNEUROSCI.22-03-00959.2002","article-title":"Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus","volume":"22","author":"Cole","year":"2002","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108289_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.1617608","article-title":"Hypoxia regulates TSC1\/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling","volume":"22","author":"Deyoung","year":"2008","journal-title":"Gene Dev."},{"key":"10.1016\/j.neuropharm.2020.108289_bib15","doi-asserted-by":"crossref","first-page":"R355","DOI":"10.1152\/ajpregu.00462.2015","article-title":"Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity","volume":"310","author":"Dunn-Meynell","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2020.108289_bib17","first-page":"489","article-title":"Definition and classification of cancer cachexia: an international consensus, the Lancet","volume":"12","author":"Fearon","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/en.2006-0539","article-title":"Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy","volume":"148","author":"Gilson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/JMN:22:1-2:93","article-title":"The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice","volume":"22","author":"Gu","year":"2004","journal-title":"J. Mol. Neurosci. : M. Inc."},{"key":"10.1016\/j.neuropharm.2020.108289_bib20","first-page":"58","article-title":"Nutritional interventions for cancer-induced cachexia","volume":"35","author":"Gullett","year":"2011","journal-title":"Curr. Probl. Canc."},{"key":"10.1016\/j.neuropharm.2020.108289_bib21","series-title":"Neurobiology of Food and Fluid Intake","first-page":"349","article-title":"Anorexia during disease","author":"Langhans","year":"2004"},{"key":"10.1016\/j.neuropharm.2020.108289_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0361-9230(99)00212-9","article-title":"Distribution of prolactin-releasing peptide mRNA in the rat brain","volume":"51","author":"Lee","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.108289_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00491754","volume":"85","author":"Liposits","year":"1986","journal-title":"Histochemistry"},{"key":"10.1016\/j.neuropharm.2020.108289_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.gt.3303016","article-title":"Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice","volume":"15","author":"Liu","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2020.108289_bib25","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis","volume":"298","author":"Lutz","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ijo.2015.28","article-title":"Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration","volume":"39","author":"Malet\u00ednsk\u00e1","year":"2015","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2020.108289_bib27","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1523\/JNEUROSCI.3464-14.2015","article-title":"Negative energy balance blocks neural and behavioral responses to acute stress by \u201dsilencing\u201d central glucagon-like peptide 1 signaling in rats","volume":"35","author":"Maniscalco","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108289_bib28","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1177\/014860719201600603","article-title":"Cytokines and their role in the pathophysiology of cancer cachexia","volume":"16","author":"Mcnamara","year":"1992","journal-title":"J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.neuropharm.2020.108289_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuroscience.2006.04.023","article-title":"Prolactin-releasing peptide is a potent mediator of stress responses in the brain through the hypothalamic paraventricular nucleus","volume":"141","author":"Mera","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108289_bib30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2826.2010.01993.x","article-title":"Stress response of prolactin-releasing peptide knockout mice as to glucocorticoid secretion","volume":"22","author":"Mochiduki","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2020.108289_bib32","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2020.108289_bib33","doi-asserted-by":"crossref","first-page":"26991","DOI":"10.1038\/srep26991","article-title":"Aerobic exercise and pharmacological treatments counteract cachexia by modulating autophagy in colon cancer","volume":"6","author":"Pigna","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.108289_bib34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"Faseb. J.: off.pub.Fed Am.Soc.Exp.Bio"},{"key":"10.1016\/j.neuropharm.2020.108289_bib35","doi-asserted-by":"crossref","DOI":"10.1017\/S0029665112000778","article-title":"The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance","volume":"71","author":"Riediger","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.neuropharm.2020.108289_bib36","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108289_bib37","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1210\/endo.140.12.7211","article-title":"Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery","volume":"140","author":"Roland","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cne.21407","article-title":"Identification of rat brainstem neuronal structures activated during cancer-induced anorexia","volume":"504","author":"Ruud","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","article-title":"Cancer cachexia: diagnosis, assessment, and treatment","volume":"127","author":"Sadeghi","year":"2018","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.108289_bib41","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000064427","article-title":"Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus","volume":"76","author":"Seal","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fendo.2014.00170","article-title":"Functions of two distinct \u201dprolactin-releasing peptides\u201d evolved from a common ancestral gene","volume":"5","author":"Tachibana","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108289_bib44","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1172\/JCI34682","article-title":"Endogenous prolactin-releasing peptide regulates food intake in rodents","volume":"118","author":"Takayanagi","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2020.108289_bib45","first-page":"139","article-title":"Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown","volume":"629","author":"Taxman","year":"2010"},{"key":"10.1016\/j.neuropharm.2020.108289_bib46","doi-asserted-by":"crossref","first-page":"E221","DOI":"10.1152\/ajpendo.2001.280.2.E221","article-title":"Myostatin inhibits cell proliferation and protein synthesis in C2 C12 muscle cells","volume":"280","author":"Taylor","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2020.108289_bib47","first-page":"396","article-title":"The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome","volume":"20","author":"van Norren","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.neuropharm.2020.108289_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2016-000097","article-title":"Cachexia in cancer: what is in the definition?","volume":"3","author":"Vanhoutte","year":"2016","journal-title":"BMJ Open Gastroenterology"},{"key":"10.1016\/j.neuropharm.2020.108289_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/ijms18050986","article-title":"Oral treatment with the ghrelin receptor agonist HM01 attenuates cachexia in mice bearing colon-26 (C26) tumors","volume":"18","author":"Villars","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108289_bib50","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","article-title":"Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108289_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108289_bib52","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1073\/pnas.1521919112","article-title":"mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.108289_bib53","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00429-014-0841-6","article-title":"Glutamatergic phenotype of glucagon-like peptide 1 neurons in the caudal nucleus of the solitary tract in rats","volume":"220","author":"Zheng","year":"2015","journal-title":"Brain Struct. Funct."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:06:44Z","timestamp":1758438404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":53,"alternative-id":["S0028390820303579"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108289","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108289"}}